Clinical efficacy of amphotericin B colloidal dispersion against infections caused by Candida spp

Chemotherapy

Volumn 45, Issue SUPPL. 1, 1999, Pages 27-33

  Dupont, B ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

ABCD; Amphocil; Amphotericin B; Candida spp; Colloidal dispersion; Systemic candidiasis

Indexed keywords

AMPHOTERICIN B CHOLESTEROL SULFATE; ANTIFUNGAL AGENT;

ARTICLE; CANDIDIASIS; CLINICAL TRIAL; DRUG EFFICACY; HUMAN; LIVER TOXICITY; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NEPHROTOXICITY; PRIORITY JOURNAL;

AMPHOTERICIN B; ANTIBIOTICS, ANTIFUNGAL; CANDIDIASIS; CLINICAL TRIALS; FUNGEMIA; HUMANS; MULTICENTER STUDIES; TREATMENT OUTCOME;

EID: 0033028190     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000048467     Document Type: Article

References (26)

1. Maksymiuk AW, Thongprasert S, Hopfer R, Luna, Fainstein V, Bodey GP: Systemic candidiasis in cancer patients. Am J Med 1984;77(suppl 4D):20-27.
2. Paya CV: Fungal infections in solid-organ transplantation. Clin Infect Dis 1993;16:677-688.
3. Sobel JD, Vazquez J: Candidemia and systemic candidiasis. Semin Resp Infect 1990;5:123-137.
4. Rex JH, Bennett JE, Sugar AM, Pappas PG, van der Horst CM, Edwards JE, Washburn RG, Scheld WM, Karchmer AW, Dine AP, et al: A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. New Engl J Med 1994;331:1325-1330.
5. British Society for Antimicrobial Chemotherapy Working Party: Management of deep Candida infection in surgical and intensive care unit patients. Intens Care Med 1994;20:522-528.
6. Kujath P, Lerch K, Kochendorfer P, Boos C: Comparative study of the efficacy of fluconazole versus amphotericin B/flucytosine in surgical patients with systemic mycoses. Infection 1993;21:376-382.
7. Hanson LH, Stevens DA: Comparison of antifungal activity of amphotericin B deoxycholate suspension with that of amphotericin B cholesteryl sulfate colloidal dispersion. Antimicrob Agents Chemother 1992;36:486-88.
8. Janknegt R, de Marie S, Bakker-Woudenberg AJM, Crommelin DJA: Liposomal and lipid formulations of amphotericin B. Clinical pharmacokinetics. Clin Pharmacokinet 1992;23:279-291.
9. Stevens DA: Overview of amphotericin B colloidal dispersion (Amphocil). J Infect 1994;28(suppl 1):45-9.
10. Bowden RA, Cays M, Gooley T, Mamelok RD, van Burik JA: Phase I study of amphotericin B colloidal dispersion for the treatment of invasive fungal infections after marrow transplant. J Infect Dis 1996;173: 1208-1215.
11. Oppenheim BA, Herbrecht R, Kusne S: The safety and efficacy of amphotericin B colloidal dispersion in the treatment of invasive mycoses. Clin Infect Dis 1995;21: 1145-1153.
12. Anaissie E, Gurwith M: Safety and efficacy of amphotericin B colloidal dispersion (ABCD). Can J Infect Dis 1995;6(suppl C):286C, Abstract 0632.
13. Armitage P, Berry G: Statistical Methods in Medical Research (ed 2). Oxford, Blackwell Scientific, p 125.
14. Gurwith M: Clinical efficacy of amphotericin B colloidal dispersion against infections caused by Aspergillus spp. Chemotherapy 1999; 45(suppl 1):34-38.
15. Komshian SV, Uwaydah AK, Sobel JD, Crane LR: Fungemia caused by Candida species and Torutopsis glabrata in the hospitalised patient: frequency, characteristics, and evaluation of factors influencing outcome. Rev Infect Dis 1989;11:379-390.
16. Castaldo P, Stratta RJ, Wood RP, Markin RS, Patil KD, Shaefer MS, Langnas AN, Reed EC, Li S, Pillen TJ, Shaw BW: Clinical spectrum of fungal infections after orthotopic liver transplantation. Arch Surg 1991;126:149-156.
17. van't Wout JW, Novakova I, Verhagen CAH, Fibbe WE, de Pauw BE, van der Meer JWM: The efficacy of itraconazole against systemic fungal infections in neutropenic patients: a randomised comparative study with amphotericin B. J Infection 1991;22:45-52.
18. Martino P, Girmenia C, Venditti M, Micozzi A, Santilli S, Burgio VL, Mandelli F: Candida colonization and systemic infection in neutropenic patients. Cancer 1989;64: 2030-2034.
19. Besnard M, Hartmann O, Valteau-Couanet D, Robert MC, Brugieres L, Lemerle J: Systemic Candida infection in pediatric BM autotransplantation: Clinical signs, outcome and prognosis. Bone Marrow Transplant 1993;11:465-470.
20. Lin H, Liu Y, Liu C, Cheng D: Fungemia: analysis of 43 cases. J Formosan Med Assoc 1990;89:863-867.
21. Chugh KS, Sakhuja V, Jain S, Talwar P, Minz M, Joshi K, Indudhara R: High mortality in systemic fungal infections following renal transplantation in third-world countries. Nephrol Dial Transplant 1993;8: 168-172.
22. Dato V, Dajani AS: Candidemia in children with central venous catheters: Role of catheter removal and amphotericin B therapy. Pediatr Infect Dis J 1990;9:309-314.
23. Leibovitz E, Iuster-Reicher A, Amitai M, Mogilner B: Systemic candidat infections associated with use of peripheral venous catheters in neonates: A 9-year experience. Clin Infect Dis 1992;14:485-491.
24. Meunier F, Aoun M, Bitar N: Candidemia in immunocompromised patients. Clin Infect Dis 1992;14 (suppl 1):S120-125.
25. Ringden O, Meunier F, Tollemar J, Ricci P, Tura S, Kuse E, Viviani MA, Gorin NC, Klastersky J, Fenaux P, Prentice HG, Ksionski G: Efficacy of amphotericin B encapsulated in liposomes (AmBisome) in the treatment of invasive fungal infections in immunocompromised patients. J Antimicrob Chemother 1991;28(suppl B):73-82.
26. Lopez-Berestein G, Bodey GP, Fainstein V, Keating M, Frankel LS, Zeluff B, Gentry L, Mehta K: Treatment of systemic fungal infections with liposomal amphotericin B. Arch Intern Med 1989;149:2533-2536.